Compare Cardinal Health Inc (CAH) vs Solaredge Technologies Inc (SEDG) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Cardinal Health Inc vs Solaredge Technologies Inc — how do they compare? Cardinal Health Inc trades at $228.87 (market cap $53.89B), while Solaredge Technologies Inc trades at $53.35 (market cap $3.38B). The key difference: Cardinal Health Inc is far larger — about 15.9× Solaredge Technologies Inc's market cap, and Cardinal Health Inc pays a 0.89% dividend while Solaredge Technologies Inc pays none. Which is the better fit depends on your goals.
| CAH | SEDG | |
|---|---|---|
Market Cap | $53.89B | $3.38B |
Sector | Health | Technology |
52-Week High | $239.71 | $78.51 |
52-Week Low | $146.04 | $24.42 |
Enterprise Value | $58.87B | $3.31B |
Dividend Yield | 0.89% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Cardinal Health (CAH) trades at $233.66, down 0.91% in the last session, with a bullish technical signal from moving averages and strong analyst support. The company has consistently beaten earnings estimates in recent quarters, with Q1 2026 EPS of $3.17 surpassing expectations. Revenue reached $222.58 billion in 2025, though net margins remain thin at 0.62%. Recent news highlights growth potential in medical supplies, with earnings results for fiscal 2026 due August 11.
The outlook for CAH is positive, driven by earnings momentum and sector tailwinds, but risks include high leverage with debt-to-asset ratio at 16.09% and competitive pressures. Analyst consensus is bullish with a $248 price target, suggesting 6% upside. Investors should weigh solid operational cash flow against negative shareholder equity and investing outflows.
SolarEdge Technologies (SEDG) trades at $52.13, down 5.53% amid bearish technical signals and mixed fundamentals. The stock shows negative profitability with a -28.56% net margin and -72.5% ROE, though recent quarters saw earnings beats. Revenue declined from $3.1B in 2022 to $1.18B in 2025, reflecting solar market challenges. Analyst sentiment is cautious with a $35.56 consensus target below current price, while technical indicators show bearish momentum with key support at $49.
SEDG faces significant headwinds with persistent losses and declining revenue, though operational cash flow turned positive in 2025. Investment opportunity exists if solar demand recovers, but risks include intense competition, policy uncertainty, and high debt levels. The stock remains speculative with substantial downside risk to analyst targets.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Cardinal Health Inc
Cardinal Health is a leading pharmaceutical wholesaler, engaged in the sourcing and distribution of branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail-order), hospitals networks, and healthcare providers. Along with AmerisourceBergen and McKesson, the three compose well over 90% of the U.S. pharmaceutical wholesale industry. Cardinal Health also supplies medical-surgical products and equipment to healthcare facilities in North America, Europe, and Asia.
Read more on CAH →About Solaredge Technologies Inc
SolarEdge Technologies designs, develops, and sells direct current optimized inverter systems for solar photovoltaic installations. The company system consists of power optimizers, inverters, and cloud-based monitoring platform and addresses a broad range of solar market segments, from residential solar installations to commercial and small utility-scale solar installations. The company sells its products directly to solar installers, engineering, procurement, and construction firms and indirectly to solar installers through distributors and electrical equipment wholesalers. Additionally, the company has nonsolar products targeting energy storage and e-mobility.
Read more on SEDG →
